Scientists around the world say the antibody taken from Covid-19 patients is 100 percent successful. The news that comes with the spread of drugs to successfully fight coronavirus is hopeful. The antibody, previously taken from those infected with Covid-19, was injected into 10 infected patients, and the results were successful. Researchers say they feel that these 10 patients were saved by ‘one dose of antibody’ injected from the earlier survivors. They report that after the use of the antibody, all 10 of them had reduced symptoms, increased oxygen levels in their bodies, and eliminated viral problems.
This preliminary study was conducted in three hospitals in China. The report was published in the Proceedings of the National Academies of Sciences. Thus, immune antibodies collected from infected persons, called vaccinated in patients with convulsive plasma therapy. Previously, this method has been tested against polio, smallpox, mumps and flu. Previous experience has shown that it is better for some people than many other therapies. Convulsant plasma therapy has a better history of many diseases than many other forms of treatment.
The US Food and Drug Administration has approved the use of convolucent plasma therapy, as currently no vaccine is available against coronavirus. This test is mostly performed in people who are sick.
Findings
Researchers say they made some interesting discoveries. They administered a dose of convolucent plasma to a 46-year-old patient they treated. Researchers say that this therapy, which was administered to eliminate the Covid-19 virus, allowed him to recover within 24 hours. Unlike many other patients who have undergone this treatment, the symptoms go away within four days.
Researchers note that the same is true of the 10 patients they treated. A 49-year-old woman had severe Covid-19 infection. The experiment also succeeded in them. It is also important to note that they have no other illnesses. Similarly, a 50-year-old was diagnosed within 25 days after a convoluted plasma therapy.
One of the major advantages that researchers have highlighted is that not one in ten patients who undergo convalescent plasma therapy dies. One part of the patient was reddened, as was a wound on his face. Researchers say this was unexpected. Researchers say all 10 patients survived without any significant changes. All of them were treated in an emergency.
Despite this, the publication of this report says, there is still much work to be done. The main reason for this, he says, is that it still remains to be learned what level of convolucent plasma will be beneficial and at what stage the patient will benefit.
